ResMed (RMD) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7611521078

Ventilators, Mask Systems, Diagnostic Devices, Sleep Therapy Devices, Cloud-Based Software

ResMed Inc. is a leading medical technology company that develops, manufactures, and distributes innovative medical devices and cloud-based software applications for the healthcare industry.

The company operates through two main segments: Sleep and Respiratory Care, and Software as a Service. The Sleep and Respiratory Care segment focuses on providing a range of products and solutions for respiratory disorders, including ventilation devices, diagnostic products, mask systems, and dental devices.

ResMed's Software as a Service segment offers a suite of cloud-based software applications that enable healthcare providers to manage patient outcomes, streamline business processes, and improve patient engagement. Some of its notable software solutions include AirView, a remote monitoring system that allows healthcare providers to monitor and adjust patient device settings remotely; myAir, a personalized therapy management application that provides support and education to patients with sleep apnea; and U-Sleep, a compliance monitoring solution that helps home medical equipment providers streamline their sleep programs.

In addition, ResMed offers a range of out-of-hospital software solutions, including Brightree business management software, MatrixCare care management solutions, HEALTHCAREfirst's electronic health record and billing services, and MEDIFOX DAN's software solutions. These solutions cater to various healthcare providers, including home health and hospice agencies, senior living communities, and pharmacies.

ResMed's products and solutions are marketed to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and a direct sales force. With a strong presence in the healthcare industry, ResMed has established itself as a leader in sleep and respiratory care, and continues to innovate and expand its offerings to improve patient outcomes and healthcare services.

Founded in 1989, ResMed is headquartered in San Diego, California, and has become a trusted name in the healthcare industry. To learn more about ResMed and its innovative solutions, visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ResMed (RMD) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for ResMed (RMD) - Stock Price & Dividends

RMD Stock Overview

Market Cap in USD 30,828m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1995-06-02

RMD Stock Ratings

Growth 5y 35.1
Fundamental 84.2
Dividend 6.27
Rel. Performance vs Sector -1.43
Analysts 4.07/5
Fair Price Momentum 189.38 USD
Fair Price DCF 199.88 USD

RMD Dividends

Yield 12m 0.93%
Yield on Cost 5y 1.65%
Dividends CAGR 5y 3.90%
Payout Consistency 100.0%

RMD Growth Ratios

Growth 12m -3.37%
Growth Correlation 12m 33%
Growth Correlation 3m 26%
CAGR 5y 12.12%
CAGR/Mean DD 5y 0.67
Sharpe Ratio 12m -0.22
Alpha vs SP500 12m -29.92
Beta vs SP500 5y weekly 0.96
ValueRay RSI 27.79
Volatility GJR Garch 1y 29.98%
Price / SMA 50 -0.37%
Price / SMA 200 16.94%
Current Volume 2734.7k
Average Volume 20d 1043.6k

External Links for RMD Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of RMD stocks?
As of June 22, 2024, the stock is trading at USD 205.83 with a total of 2,734,710 shares traded.
Over the past week, the price has changed by -2.79%, over one month by -5.70%, over three months by +6.48% and over the past year by -4.03%.
What are the forecast for RMD stock price target?
According to ValueRays Forecast Model, RMD ResMed will be worth about 210.6 in June 2025. The stock is currently trading at 205.83. This means that the stock has a potential upside of +2.3%.
Issuer Forecast Upside
Wallstreet Target Price 214.6 4.26
Analysts Target Price 184 -10.6
ValueRay Target Price 210.6 2.30